INTRODUCTION: Sentinel node (SN) biopsy to predict axillary involvement in breast cancer patients is a common practice. After a positive SN, additional metastases are present in an unpredictable percentage, as variable as 13-66%, of axillary clearances. Our aim is to define variables associated with non-sentinel node (NSN) metastases and to determine the predictive value of a derived clinical decision rule. METHODS: A consecutive series of patients with a positive SN submitted to SN biopsy plus axillary dissection was evaluated from June 1999 to December 2004 (n=143). Patient-, tumour- and SN-related variables were analysed in relation to the presence of additional metastasis. Univariate and multivariate analyses were done and predictive values of a clinical decision rule based on significant variables were estimated. RESULTS: A total of 66 patients had metastasis in non-sentinel axillary nodes. No significant differences were present between this group and those with only the SN metastasised. Significant and independent association was found between NSN positivity and increasing tumour size, the presence of multifocality and the presence of peritumoral lymph channel invasion. CONCLUSIONS: A first derivation of a simple rule based on tumour-related variables concurs to define the presence of NSN metastasis. Care should be taken when including SNrelated variables in these algorithms.
INTRODUCTION: Sentinel node (SN) biopsy to predict axillary involvement in breast cancerpatients is a common practice. After a positive SN, additional metastases are present in an unpredictable percentage, as variable as 13-66%, of axillary clearances. Our aim is to define variables associated with non-sentinel node (NSN) metastases and to determine the predictive value of a derived clinical decision rule. METHODS: A consecutive series of patients with a positive SN submitted to SN biopsy plus axillary dissection was evaluated from June 1999 to December 2004 (n=143). Patient-, tumour- and SN-related variables were analysed in relation to the presence of additional metastasis. Univariate and multivariate analyses were done and predictive values of a clinical decision rule based on significant variables were estimated. RESULTS: A total of 66 patients had metastasis in non-sentinel axillary nodes. No significant differences were present between this group and those with only the SN metastasised. Significant and independent association was found between NSN positivity and increasing tumour size, the presence of multifocality and the presence of peritumoral lymph channel invasion. CONCLUSIONS: A first derivation of a simple rule based on tumour-related variables concurs to define the presence of NSN metastasis. Care should be taken when including SNrelated variables in these algorithms.
Authors: Thorsten Kuehn; Andreas Bembenek; Thomas Decker; Dieter Ludwig Munz; Marie-Luise Sautter-Bihl; Michael Untch; Diethelm Wallwiener Journal: Cancer Date: 2005-02-01 Impact factor: 6.860
Authors: V Ozmen; H Karanlik; N Cabioglu; A Igci; M Kecer; O Asoglu; S Tuzlali; A Mudun Journal: Breast Cancer Res Treat Date: 2006-01 Impact factor: 4.872
Authors: U Veronesi; G Paganelli; V Galimberti; G Viale; S Zurrida; M Bedoni; A Costa; C de Cicco; J G Geraghty; A Luini; V Sacchini; P Veronesi Journal: Lancet Date: 1997-06-28 Impact factor: 79.321
Authors: S F Abdessalam; E E Zervos; M Prasad; W B Farrar; L D Yee; M J Walker; W B Carson; W E Burak Journal: Am J Surg Date: 2001-10 Impact factor: 2.565
Authors: C Reynolds; R Mick; J H Donohue; C S Grant; D R Farley; L S Callans; S G Orel; G L Keeney; T J Lawton; B J Czerniecki Journal: J Clin Oncol Date: 1999-06 Impact factor: 44.544
Authors: Alberta Ferrari; Paolo Dionigi; Francesca Rovera; Luigi Boni; Giorgio Limonta; Silvana Garancini; Diego De Palma; Gianlorenzo Dionigi; Cristiana Vanoli; Mario Diurni; Giulio Carcano; Renzo Dionigi Journal: World J Surg Oncol Date: 2006-11-20 Impact factor: 2.754